Search research articles
Contact Us
Filters
Showing results (41-50 of 162) with videos related to
Page
of 17
Sort By:
The Journal of Infectious Diseases
|
February 1, 1997
The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine
M Gisslén, G Norkrans, B Svennerholm, et al.
AIDS (London, England)
|
July 15, 1997
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy
M Gisslén, L Hagberg, B Svennerholm, et al.
JAMA
|
March 14, 1980
Multiple hepatitis attacks in drug addicts
G Norkrans, G Frösner, S Hermodsson, et al.
AIDS (London, England)
|
February 10, 1998
HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir
M Gisslén, G Norkrans, B Svennerholm, et al.
Infection
|
January 1, 1976
The long-term outcome of hepatitis B
G Norkrans, S Hermodsson, P Lundin, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1979
Passive--active immunization in a neonate treated with repeated doses of high-titred hepatitis B immune globulin
S Iwarson, G Norkrans, S Hermodsson, et al.
Scandinavian Journal of Primary Health Care
|
October 1, 1989
Prevalence of hepatitis B virus markers in a random sample of women from Göteborg, Sweden
R Andersson, G Norkrans, C Bengtsson, et al.
Lakartidningen
|
May 3, 1995
[Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C]
O Weiland, G Norkrans, A Frydén, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1983
Autoantibodies to Tamm-Horsfall protein in acute and chronic hepatitis
J Lindberg, A Fasth, G Norkrans, et al.
Journal of Viral Hepatitis
|
July 8, 2000
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B
M Lindh, P Horal, A P Dhillon, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 162) with videos related to
Sort By:
Page
of 17
The Journal of Infectious Diseases
|
February 1, 1997
The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine
M Gisslén, G Norkrans, B Svennerholm, et al.
AIDS (London, England)
|
July 15, 1997
HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy
M Gisslén, L Hagberg, B Svennerholm, et al.
JAMA
|
March 14, 1980
Multiple hepatitis attacks in drug addicts
G Norkrans, G Frösner, S Hermodsson, et al.
AIDS (London, England)
|
February 10, 1998
HIV-1 RNA detectable with ultrasensitive quantitative polymerase chain reaction in plasma but not in cerebrospinal fluid during combination treatment with zidovudine, lamivudine and indinavir
M Gisslén, G Norkrans, B Svennerholm, et al.
Infection
|
January 1, 1976
The long-term outcome of hepatitis B
G Norkrans, S Hermodsson, P Lundin, et al.
Scandinavian Journal of Infectious Diseases
|
January 1, 1979
Passive--active immunization in a neonate treated with repeated doses of high-titred hepatitis B immune globulin
S Iwarson, G Norkrans, S Hermodsson, et al.
Scandinavian Journal of Primary Health Care
|
October 1, 1989
Prevalence of hepatitis B virus markers in a random sample of women from Göteborg, Sweden
R Andersson, G Norkrans, C Bengtsson, et al.
Lakartidningen
|
May 3, 1995
[Half of the patients respond to interferon treatment. Combination therapy is an alternative in chronic hepatitis C]
O Weiland, G Norkrans, A Frydén, et al.
International Archives of Allergy and Applied Immunology
|
January 1, 1983
Autoantibodies to Tamm-Horsfall protein in acute and chronic hepatitis
J Lindberg, A Fasth, G Norkrans, et al.
Journal of Viral Hepatitis
|
July 8, 2000
Hepatitis B virus DNA levels, precore mutations, genotypes and histological activity in chronic hepatitis B
M Lindh, P Horal, A P Dhillon, et al.
Page
of 17